MINDFUL-OBOT: Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 11, 2018

Primary Completion Date

February 3, 2020

Study Completion Date

February 3, 2020

Conditions
Opioid-use DisorderAnxietyDepressionStress Related Disorder
Interventions
BEHAVIORAL

M-ROCC

"1. LDM (Low-Dose Mindfulness): A 4-wk intro mindfulness program for OUD, 50 min/week including explicit training in use of mobile mindfulness apps, with rolling admission and ascending practice dose ladder.~2. MTPC (Mindfulness Training for Primary Care): An eight-week intensive mindfulness group with ascending practice dose ladder and skill integration over 8 weeks \& 120 minutes/wk.~3. MCS (Mindfulness Maintenance Check-in Support): Ongoing weekly mindfulness group with check-in and reminders, leveraging mobile mindfulness apps and motivational counseling for grads of LDM for 50 mins/wk.~After completion of the LDM group, participation in various levels is fluid based on patient motivation, choice, and readiness."

Trial Locations (1)

02143

Cambridge Health Alliance, Somerville

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Cambridge Health Alliance

OTHER

NCT03798431 - MINDFUL-OBOT: Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment | Biotech Hunter | Biotech Hunter